 |
afamelanotide |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous variants of porphyria (which includes treatment and prevention of cutaneous manifestations of disease) |
| USA Market Approval | USA |
| USA Designation Date | 2016-02-04 00:00:00 |
| Sponsor | Clinuvel Inc.;40 Worth Street, Suite 1053;New York, New York, 10013 |
